{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:42:54Z","timestamp":1648892574296},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s11904-005-0003-9","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T05:26:04Z","timestamp":1180070764000},"page":"116-121","source":"Crossref","is-referenced-by-count":0,"title":["HIV-associated tuberculosis and cryptococcosis in resource-limited settings"],"prefix":"10.1007","volume":"2","author":[{"given":"Umesh G.","family":"Lalloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida C.","family":"Amod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3_CR1","unstructured":"Salif Sow P: TB and HIV. Programs and abstracts of the 15th International AIDS Conference [abstract TuPL06]. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, et al.: The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163:1009\u20131021.","journal-title":"Arch Intern Med"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","volume":"16","author":"N French","year":"2002","unstructured":"French N, Gray K, Watera C, et al.: Cryptococcal infection in a cohort of HIV-1 infected Ugandan adults. AIDS 2002, 16:1031\u20131038.","journal-title":"AIDS"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","volume":"14","author":"JG Hakim","year":"2000","unstructured":"Hakim JG, Gangaidzo IT, Heyderman RS: Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective trial of 406 predominantly adult patients. AIDS 2000, 14:1401\u20131407.","journal-title":"AIDS"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","volume":"48","author":"RA Larsen","year":"2004","unstructured":"Larsen RA, Bauer M, Thomas AM, et al.: Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother 2004, 48:985\u2013991.","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR6","volume-title":"World Health Organization Global Tuberculosis Programme","author":"Treatment of tuberculosis","year":"2003","unstructured":"Treatment of tuberculosis: guidelines for national programmes [WHO\/CDS\/TB\/2003.313]. In World Health Organization Global Tuberculosis Programme, edn 3. Geneva: World Health Organization; 2003.","edition":"edn 3"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.55.091902.103753","volume":"55","author":"BC Jong de","year":"2004","unstructured":"de Jong BC, Israelski DM, Corbett EL, et al.: Clinical management of tuberculosis in the context of HIV infection. Annu Rev Med 2004, 55:283\u2013301.","journal-title":"Annu Rev Med"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJM199106063242307","volume":"324","author":"PF Barnes","year":"1991","unstructured":"Barnes PF, Bloch AB, Davidson PT, et al.: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991, 324:1644\u20131650.","journal-title":"N Engl J Med"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199101313240503","volume":"324","author":"PM Small","year":"1991","unstructured":"Small PM, Schecter GF, Goodman PC, et al.: Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991, 324:289\u2013294.","journal-title":"N Engl J Med"},{"key":"3_CR10","unstructured":"Golhar DA, Bora PC, Vasvani D, et al.: Profile of tuberculosis (TB) with HIV-AIDS in 350 patients at community care center, Mumbai [abstract B10428]. Program and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR11","unstructured":"Nissapatorn V, Kuppusamy I, Rohela M, et al.: Tuberculosis in HIV\/AIDS patients: a Malaysian experience [abstract B10252]. Programs and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR12","doi-asserted-by":"crossref","unstructured":"Swaminathan S, Iliayas S, Padmapriyadarsini C, et al.: Randomised clinical trial of 6-month versus 9-month anti-tuberculosis treatment in HIV+ individuals with pulmonary TB [abstract 141]. Programs and abstracts of the 12 Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 22\u201325, 2005.","DOI":"10.1310\/EYBU-95QU-J9JM-JC1E"},{"key":"3_CR13","unstructured":"Kizito J, Nabiryo NC, Coutinho GA, et al.: Challenges of tuberculosis management among HIV-positive persons in Uganda, TASO experience 1997\u20132002 [abstract MoPeB3181]. Program and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR14","unstructured":"Wilson D, Nachega J, Chaisson R, et al.: Validation of expanded case definitions for smear negative tuberculosis in HIV-infected South African adults [abstract MoPeB3229]. Program and abstracts of the 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.317.7159.625","volume":"317","author":"D Wilkinson","year":"1998","unstructured":"Wilkinson D, Squire SB, Garner P: Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomized placebo controlled trials. BMJ 1998, 317:625\u2013629.","journal-title":"BMJ"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","volume":"13","author":"HC Bucher","year":"1999","unstructured":"Bucher HC, Griffith LE, Guyatt GH, et al.: Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomised controlled trials. AIDS 1999, 13:501\u2013507.","journal-title":"AIDS"},{"key":"3_CR17","first-page":"735","volume":"52","author":"Centers for Disease Control and Prevention (CDC); American Thoracic Society","year":"2003","unstructured":"Centers for Disease Control and Prevention (CDC); American Thoracic Society: Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:735\u2013739.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","volume":"17","author":"G Churchyard","year":"2003","unstructured":"Churchyard G, Fielding K, Charalambous S, et al.: Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 2003, 17:2063\u20132070.","journal-title":"AIDS"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/ajrccm.159.3.9804147","volume":"159","author":"J Murray","year":"1999","unstructured":"Murray J, Sonnenberg P, Shearer SC, et al.: Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999, 159:733\u2013740.","journal-title":"Am J Respir Crit Care Med"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"HM Blumberg","year":"2003","unstructured":"Blumberg HM, Burman WJ, Chaisson RE, et al.: American Thoracic Society\/Centers for Disease Control and Prevention\/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003, 167:603\u2013662.","journal-title":"Am J Respir Crit Care Med"},{"key":"3_CR21","first-page":"79","volume-title":"Tuberculosis and HIV\/AIDS. Johannesburg","author":"HIV Policy Guideline","year":"2000","unstructured":"HIV Policy Guideline. Tuberculosis and HIV\/AIDS. Johannesburg, South Africa: Department of Health South Africa; 2000:79."},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200241090-00004","volume":"41","author":"LF Lopez-Cortes","year":"2002","unstructured":"Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, et al.: Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis. Clin Pharmacokinet 2002, 41:681\u2013690.","journal-title":"Clin Pharmacokinet"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00126334-200408010-00006","volume":"36","author":"C Jack","year":"2004","unstructured":"Jack C, Lalloo U, Abdool Karim Q, et al.: A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004, 36:929\u2013934. This is a pilot study showing the efficacy of concurrent HAART and tuberculosis treatment in resource-limited settings.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3_CR24","unstructured":"Manosuthi W, Sungkanuparph S, Vibhagool A, et al.: A randomized controlled trial of efavirenz 600 mg\/day versus 800 mg\/day in HIV-infected patients with tuberculosis to study plasma efavirenz level, virological and immunological outcomes: a preliminary result [abstract MoOrB1013]. Program and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR25","unstructured":"Drug-induced hepatitis in healthy volunteers receiving rifampicin 600 mg daily in combination with ritonavir 100 mg and saquinavir 1000 mg twice daily (ritonavir-boosted saquinavir). Roche safety letter. Nutley, NJ: Hoffmann-La Roche Inc; 2005."},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200404300-00004","volume":"18","author":"S Abdool Karim","year":"2004","unstructured":"Abdool Karim S, Abdool Karim Q, Friedland G, et al.: Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS 2004, 18:975\u2013980.","journal-title":"AIDS"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","volume":"190","author":"K Dheda","year":"2004","unstructured":"Dheda K, Lampe FC, Johnson MA, et al.: Outcome of HIVassociated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004, 190:1670\u20131676. This is a retrospective study of the clinical outcomes of patients with tuberculosis before and with HAART.","journal-title":"J Infect Dis"},{"key":"3_CR28","unstructured":"Sungkanuparph S, Manosuthi W, Kiertiburanakul S, et al.: Antiretroviral therapy in advanced HIV-infected patients with active tuberculosis [abstract MoOrB1015]. Program and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR29","volume-title":"A Randomized Controlled Trial to Assess the Effect of Integrated Tuberculosis and HIV Care on the Incidence of AIDS-defining Conditions and Mortality in Participants Co-infected with Tuberculosis and HIV","author":"START (Starting Tuberculosis and Antiretroviral Therapy)","year":"2004","unstructured":"START (Starting Tuberculosis and Antiretroviral Therapy): A Randomized Controlled Trial to Assess the Effect of Integrated Tuberculosis and HIV Care on the Incidence of AIDS-defining Conditions and Mortality in Participants Co-infected with Tuberculosis and HIV. Bethesda, MD: CAPRISA, University of KwaZulu Natal, Division of AIDS, NIAID, NIH, South Africa; 2004."},{"key":"3_CR30","unstructured":"Uwah A, Badaru S, Ekong E, et al.: Evaluating the integration of antiretroviral therapy into existing tuberculosis directly observed (DOT) program in Nigeria [abstract TuPeB4564]. Program and abstracts of the 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","volume":"158","author":"M Narita","year":"1998","unstructured":"Narita M, Ashkin D, Hollender ES, et al.: Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998, 158:157\u2013161.","journal-title":"Am J Respir Crit Care Med"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/00126334-200412150-00007","volume":"37","author":"N Kumarsamy","year":"2004","unstructured":"Kumarsamy N, Sreekanth C, Mayer K, et al.: Incidence of immune reconstitution syndrome in HIV\/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 2004, 37:1574\u20131576.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0035-9203(98)91036-7","volume":"92","author":"AD Harries","year":"1998","unstructured":"Harries AD, Nyangulu DS, Kangombe C, et al.: Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi. Trans R Soc Trop Med Hyg 1998, 92:343\u2013347.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3_CR34","first-page":"919","volume":"2","author":"C Connolly","year":"1998","unstructured":"Connolly C, Davies GR, Wilkison D: Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991\u20131995. Int J Tuberc Lung Dis 1998, 2:919\u2013925.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3_CR35","unstructured":"Collins JA, Villena J, Gutierrez L, et al.: Effect of antiretroviral therapy on survival of a cohort of Peruvian HIV-infected tuberculosis patients [abstract MoPeB3180]. Program and abstracts of 15th International AIDS Conference. Bangkok, Thailand, July 11\u201316, 2004."},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/313910","volume":"31","author":"SB Gordon","year":"2000","unstructured":"Gordon SB, Walsh AL, Chaponda M: Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe and seasonal. Clin Infect Dis 2000, 31:53\u201357.","journal-title":"Clin Infect Dis"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/314836","volume":"180","author":"LK Archibald","year":"1999","unstructured":"Archibald LK, McDonald LC, Rheanpumikankit S: Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients > 15 years old, Bangkok. J Infect Dis 1999, 180:87\u201392.","journal-title":"J Infect Dis"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/00002030-200012010-00019","volume":"14","author":"LJ Elden van","year":"2000","unstructured":"van Elden LJ, Walenkamp AM, Lipovsky MM: Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000, 14:2787\u20132788.","journal-title":"AIDS"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen R, et al.: Practice guidelines for the management of cryptococcal disease. Infectious Disease Society of America. Clin Infect Dis 2000, 30:710\u2013718.","journal-title":"Clin Infect Dis"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","volume":"326","author":"MS Saag","year":"1992","unstructured":"Saag MS, Powderly WG, Cloud GA, et al.: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992, 326:83\u201389.","journal-title":"N Engl J Med"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jac\/dkg399","volume":"52","author":"K Datta","year":"2003","unstructured":"Datta K, Jain N, Sethi S, et al.: Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. J Antimicrob Chemother 2003, 52:683\u2013686.","journal-title":"J Antimicrob Chemother"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, et al.: Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 2004, 363:1764\u20131767.","journal-title":"Lancet"},{"key":"3_CR43","first-page":"48","volume-title":"Prevention and Treatment of Opportunistic and HIV-related Diseases in Adults","author":"HIV Policy Guideline","year":"2000","unstructured":"HIV Policy Guideline. Prevention and Treatment of Opportunistic and HIV-related Diseases in Adults. Johannesburg, South Africa: Department of Health South Africa; 2000:48\u201350."},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00126334-200305010-00019","volume":"33","author":"S Sungkanuparph","year":"2003","unstructured":"Sungkanuparph S, Vibhagool A, Mootsikapun P, et al.: Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. J Acquir Immune Defic Syndr 2003, 33:118\u2013119. This is a clinical study showing the efficacy of efavirenz in patients with cryptococcal meningitis.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","volume":"36","author":"A Vibhagool","year":"2003","unstructured":"Vibhagool A, Sungkanuparph S, Mootsikapun P, et al.: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis 2003, 36:1329\u20131331.","journal-title":"Clin Infect Dis"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","volume":"38","author":"C Mussini","year":"2004","unstructured":"Mussini C, Pezzotti P, Miro JM, et al.: Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin Infect Dis 2004, 38:565\u2013571.","journal-title":"Clin Infect Dis"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-005-0003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-005-0003-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-005-0003-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:15:38Z","timestamp":1559434538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-005-0003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11904-005-0003-9","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}